InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Singh Harvinder. Director active across 1 company, notably Integra Lifesciences Holdings CORP. Aggregated, 4 filings have been published. Activity tracked since 10 March 2024. The latest transaction was disclosed on 12 October 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条